Anthropic says the tool was designed to stop abuse and AI model extraction, but critics questioned the use of undisclosed ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...